INS and metabolic dysfunction-associated steatotic liver disease: Several pivotal factors have been identified as mediators of hepatic insulin sensitivity, including hepatic bile acid-FXR signaling during feeding and the bilirubin–PPARα axis during fasting; when these critical pathways become dysfunctional, the progression to MASLD commences.